CaroGen has raised $1 million through an organization based in Shandong, China. The $1 million investment will be used to advance the company’s Hepatitis B Virus development in the U.S. … more

Starting next year, Protein Sciences will distribute its Flublok Quadrivalent shot, which targets four strains of the virus. The private biotech aims to quash the idea that its vaccines are only for people who are allergic to eggs … more

After a decades-long embargo, the United States is loosening restrictions on Cuba — and that’s opening up cross-border collaborations in vaccine research … more

Vaccines save thousands of lives in the United States every year, but many adults remain unvaccinated. Low rates of vaccine uptake lead to costs to individuals and society … more